Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
58,225
+10,030
+21% +$1.82M 0.04% 364
2026
Q1
$9.14M Buy
48,195
+10,492
+28% +$2.23M 0.05% 352
2025
Q4
$8.63M Buy
37,703
+6,709
+22% +$1.47M 0.05% 342
2025
Q3
$6.11M Buy
30,994
+4,522
+17% +$900K 0.04% 374
2025
Q2
$5.22M Buy
26,472
+1,173
+5% +$227K 0.04% 360
2025
Q1
$5.2M Buy
25,299
+1,984
+9% +$433K 0.06% 288
2024
Q4
$5.47M Buy
23,315
+8,963
+62% +$2.2M 0.07% 261
2024
Q3
$3.99M Buy
14,352
+9,323
+185% +$2.47M 0.08% 243
2024
Q2
$1.26M Buy
+5,029
New +$1.27M 0.06% 291

Other funds holding DHR

&Partners's DHR Position: Q2 2026 in Review

&Partners increased its Danaher (DHR) stake by 21% in Q2 2026, buying an estimated $1.82M and bringing the position to 58,225 shares worth $10.8M. The position accounts for 0.04% of the portfolio, ranked #364.

&Partners first reported a position in DHR in Q2 2024 and has held it in 9 quarters since. 2,107 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • &Partners held 58,225 shares of Danaher worth $10.8M as of Q2 2026.
  • &Partners bought 10,030 Danaher shares in Q2 2026, an estimated $1.82M.
  • Danaher made up 0.04% of &Partners's portfolio in Q2 2026, its #364 holding.
  • &Partners first reported a position in Danaher in Q2 2024 and has held it in 9 quarters since.
  • 2,107 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.